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Objective. Excessive gestational weight gain (GWG) is associated with adverse maternal and child outcomes and contributes to
obesity in women. Our aim was to identify early pregnancy factors associated with excessive GWG, in a contemporary nulliparous
cohort. Methods. Participants in the SCOPE study were classified into GWG categories (“not excessive” versus “excessive”) based
on pregravid body mass index (BMI) using 2009 Institute of Medicine (IOM) guidelines. Maternal characteristics and pregnancy
risk factors at 14–16 weeks were compared between categories and multivariable analysis controlled for confounding factors.
Results. Of 1950 women, 17% gained weight within the recommended range, 74% had excessive and 9% inadequate GWG. Women
with excessive GWG were more likely to be overweight (adjOR 2.9 (95% CI 2.2–3.8)) or obese (adjOR 2.5 (95% CI 1.8–3.5))
before pregnancy compared to women with a normal BMI. Other factors independently associated with excessive GWG included
recruitment in Ireland, younger maternal age, increasing maternal birthweight, cessation of smoking by 14–16 weeks, increased
nightly sleep duration, high seafood diet, recent immigrant, limiting behaviour, and decreasing exercise by 14–16 weeks. Fertility
treatmentwas protective.Conclusions. Identification of potentiallymodifiable risk factors for excessiveGWGprovides opportunities
for intervention studies to improve pregnancy outcome and prevent maternal obesity.
1. Introduction
The Institute of Medicine (IOM) guidelines for pregnancy
weight gain were initially developed in 1990 to promote
adequate gestational weight gain (GWG) with the goal of
preventing premature births and small-for-gestational-age
infants [1]. However, with increasing numbers of women
entering pregnancy overweight and obese, the IOM guide-
lines for pregnancyweight gainwere recently updated in 2009
with a shift of focus towards maternal health outcomes and
reduction of postpartumweight retention and childhood adi-
posity [2].The updated 2009 IOMguidelines for GWGutilise
standard body mass index (BMI) categories developed by the
World Health Organisation and provide a relatively narrow
GWG target for obese women in pregnancy (Table 1) [2].
The increasing prevalence of overweight and obesity
has created a global epidemic with associated substantial
personal and health care costs. Excessive GWG increases
Hindawi Publishing Corporation
Journal of Obesity
Volume 2014, Article ID 148391, 9 pages
http://dx.doi.org/10.1155/2014/148391
2 Journal of Obesity
Table 1: Institute of Medicine guidelines for recommended gesta-
tional weight gain based on prepregnancy body mass index [5].
Body mass index Gestational weight gain (kg/wk)
Low Normal Excessive
Normal weight
(18.5–24.9 kg/m2) <0.35 0.35–0.50 >0.50
Overweight
(25.0–29.9 kg/m2) <0.23 0.23–0.33 >0.33
Obese (≥30.0 kg/m2) <0.17 0.17–0.27 >0.27
the likelihood of postpartum weight retention and long-term
weight gain and is an important contributor to the obesity
epidemic among women [3, 4].
Women who gain weight in excess of the 2009 IOM
recommendations also have an increased risk of adverse
maternal and child outcomes [2]. Specifically, excessive GWG
has been associated with an increased risk of hypertensive
disorders of pregnancy [5, 6], large for gestational age
(LGA) infants [6–10], and nonelective Caesarean delivery
[6, 9–11]. Excessive GWG has also been associated with the
development of childhood adiposity and obesity, thereby
contributing to obesity in both mothers and their offspring
[12–15]. Mechanistically, excessive GWG may expose the
developing fetus to persistently raised concentrations of
glucose, insulin, amino acids, and lipids as well as inflam-
matory cytokines derived from maternal adipose tissue [16].
During periods of developmental plasticity, it is hypothesised
that fetal pathways of energy balance may be permanently
“reset” by this adverse environment, leading to a metabolic
predisposition to obesity [15, 17]. Alternatively, or in addition,
heritable predisposition to gain weight or common lifestyle
factors which promote weight gain (e.g., low levels of physical
activity, high energy diet) may contribute to the shared risk of
obesity between mother and child [16].
In previous reports, risk of excessive GWG has been
variously associatedwith themother’s prepregnancy BMI and
dietary and lifestyle behaviours [18–32]. Parity has seldom
been considered, although risk factors may differ between
nulliparous and parous women due to differences in lifestyle
and family environment. Since more than 40% of births
in western countries typically occur in nulliparous women
[33–35], we aimed to identify early pregnancy risk factors
for excessive GWG in nullipara. This study was undertaken
using data on GWG in women recruited to the screening for
pregnancy endpoints (SCOPE) cohort, a large international
study of healthywomen in their first pregnancies.We recently
reported that more than 70% of women in this study had
excessive GWG according to the recent IOM guidelines [36].
We proposed that identification of risk factors might allow
the development of targeted strategies and interventions to
help women at the greatest risk achieve optimal weight gain
during their pregnancy and lower their risk of obstetric
complications and future obesity for both themselves and
their infants.
2. Materials and Methods
2.1. StudyDesign andEthics Approval. Thescreening for preg-
nancy endpoints (SCOPE) study is a prospective, multicentre
cohort study with primary aims of developing screening
tests to identify women at risk of preeclampsia, small-
for-gestational-age (SGA) infants, and spontaneous preterm
birth and is registered with the Australia New Zealand
Clinical Trial Registry: ACTRN12607000551493. The partici-
pants comprised healthy nulliparous women with singleton
pregnancies. Full details of the study design and methods
have been published elsewhere [37, 38]. Participants in this
component of the SCOPE study were recruited between
November 2004 and February 2011, in Adelaide, Australia,
Auckland, New Zealand, and Cork, Ireland.The three United
Kingdom SCOPE centres (Manchester, Leeds, and London)
were not included in this study of GWG due to the fact that
end of pregnancy weights were not being routinely recorded.
Ethical approval was obtained from local ethics committees
(Australia REC 1712/5/2008, New Zealand AKX/02/00/364,
and Cork ECM5 (10) 05/02/08) and all participants provided
written informed consent.
All participants were seen at 14–16 weeks of gestation at
which time they completed an extensive interview. Physical
measurements including height and weight were measured
by a research midwife during this visit. The data were then
entered into an internet accessed central database with a
complete audit trail (MedSciNetAB, Stockholm, Sweden).
Participants were followed prospectively and data on preg-
nancy outcome were collected by a research midwife, usually
within 72 hours of birth. Women included in this study
comprised those who had weight recorded at 14–16 weeks
of gestation and at the end of pregnancy. The total GWG
for the second and third trimesters were calculated and
categories of weight gain were assigned according to 2009
IOM guidelines [2]. In order to estimate as accurately as
possible prepregnancy BMI, 1.25 kg (the average of 0.5–2.0 kg
weight gain in the first trimester reported in the IOM 2009
guideline) was subtracted from each participant’s weight at
14–16 weeks of gestation [2, 18]. Prepregnancy BMI was then
categorised according to WHO criteria (underweight BMI
<18.5 kg/m2, normal BMI 18.5–24.9 kg/m2, overweight BMI
25.0–29.9 kg/m2, and obese BMI ≥ 30.0 kg/m2). Exclusion
criteria in this study are outlined in Figure 1. Women who
were underweight were excluded due to small numbers.
Each participant’s weight gain per week in the second and
third trimester was adjusted for the gestation at delivery
and calculated by the following formula: GWG (kg/week)
= total weight gain (kg)/(week at final weight measurement
− week at first visit measurement) [18, 39]. For 49% of the
total SCOPE cohort, the gestational week at which the final
weight measurement was recorded was not recorded. These
participants were excluded from the current study (Figure 1).
Participants were classified as gaining “less than,” “within,”
or “exceeding” the recommended rates of weight gain based
on their prepregnancy BMI group [2]. The groups of women
who gained below or within the recommended ranges (“not
excessive GWG”)were then compared to those who exceeded
the ranges for GWG (“excessive GWG”).
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Study population (n = 1950)
Ineligible status after recruitment (n = 13)
Missing outcome data (n = 43)
Terminations ≥ 20 weeks due to anomalies or other reasons
Missing end of pregnancy weight (n = 1022)
Missing gestation for end of pregnancy weight (n = 1854)
n = 115)Underweight prepregnancy BMI category (
Auckland (n = 264) Adelaide (n = 475) Cork (n = 1211)
Recruited to study at 14–16 weeks (n = 5026)
Study population at 14–16 weeks’ (n = 4970)
(n = 12)
Miscarriage or termination 15–19[6] weeks (n = 17)
Figure 1: Recruitment flow chart.
2.2. Definitions. Theestimated date of deliverywas calculated
from a certain last menstrual period (LMP) date and was
only adjusted if either (1) a scan performed at <16 weeks
of gestation found a difference of ≥7 days between the scan
gestation and that calculated by the LMP or (2) on 20-week
scan a difference of ≥10 days was found between the scan
gestation and that calculated from the LMP. If the LMP date
was uncertain, then scan dates were used to calculate the
estimated date of delivery. Socioeconomic index, a measure
of socioeconomic status (higher score indicating a higher
status), was based on the New Zealand socioeconomic index
[40]. Fertility treatment was defined as any treatment given
to assist conception of the current pregnancy, including hor-
monal treatment, artificial insemination, in vitro fertilisation,
and intra-cytoplasmic sperm injection. High fish or seafood
intake was defined as ≥3 servings of any fish (including oily
fish such as tuna or salmon) or seafood (including shellfish or
shrimps) per week. The limiting behaviour score is adapted
from the “Behavioural Responses to Illness Questionnaire”
and assesses the extent to which a participant has limited
their normal activities and exercise since becoming pregnant
[41]. A higher limiting score reflects greater limitation of
activities. Pregnancy-induced hypertension included either
gestational hypertension defined as sBP ≥ 140mmHg and/or
dBP ≥ 90mmHg on at least 2 occasions 4 hours apart
after 20 weeks of gestation but before the onset of labour
or preeclampsia defined as gestational hypertension plus
proteinuria ≥300mg/24 h or spot urine protein : creatinine
ratio ≥30mg/mmol creatinine or urine dipstick protein ≥
++ or any multisystem disease [42]. SGA and LGA were
defined as birth weight less than the 10th and greater than
the 90th customised centile, respectively, and were adjusted
for maternal height, booking weight, and ethnicity as well as
gestational age at delivery and sex of the infant [43].
2.3. Statistical Analysis. All analyses were performed using
the statistical software package SPSS 19 (SPSS Inc., version
19.0, Chicago, IL, USA). Categorical and continuous variables
were analysed byChi-square tests and Student’s t-test, respec-
tively, to compare maternal demographic and lifestyle factors
with “excessive” versus “not excessive” gestational weight gain
categories. Statistical significance was defined at the 5% level.
In total, univariable analyses were performed on 300
variables of interest based on a priori knowledge using binary
logistic regression modelling to assess the risk of excessive
gestational weight gain. Variables were then excluded due to
a P value >0.1 (205 variables), variables with >10% missing
data (20 variables), and variables with a cell count <5 (10
variables). Of the remaining 65 variables, 21 were selected
for multivariable modelling based on known risk factors or
variables of interest. The initial variable list used to create
the multivariable model is available as a supporting file
in Supplementary Table 1A in the Supplementary Material
available online at http://dx.doi.org/10.1155/2014/148391 and
the remaining 44 variables deleted are in a supporting file in
Supplementary Table 1B. Of the selected variables, data were
complete in>99%of participants for each variable except par-
ticipants’ birth weight (4.15% missing data). Data for missing
variables were imputed using the mode for categorical data
variables (𝑛 = 2) and expectation maximization (𝑛 = 1) or
median (𝑛 = 2) for continuous data variables. Multivariable
analysis using a backward stepwise method controlling for
each variable in the model was performed.
3. Results
5026 nulliparous women with singleton pregnancies were
recruited into the SCOPE study from the three participating
centres. Of these women, 1950 were eligible for the current
study, 475 from Adelaide, 264 from Auckland, and 1211
from Cork (Figure 1). The demographics of those who were
included compared to those who were excluded for the three
participating SCOPE centres are shown inTable 2.Therewere
no significant differences in either Auckland or Cork, whilst
those who participated in the current study from Adelaide
were slightly older (24.3 versus 23.4 years), had a slightly
higher BMI (27.5 versus 26.7 kg/m2), and were less likely
to smoke (20 versus 27%). The main reasons for exclusion
were missing data for end of pregnancy weight or gestation
at which the end of pregnancy weight was recorded. The
average weight gain from 14–16 weeks of gestation until the
last weight measured in pregnancy was 12.31±5.26 kg across
the cohort and was normally distributed. The estimated total
weight gain [2] for this study cohort from conception until
end of pregnancy was 13.55 kg, 13.91 ± 4.62 kg for normal,
13.76 ± 5.19 kg for overweight, and 11.82 ± 7.18 kg for obese
women. Only 335 women (17.2%) gained weight within the
ranges recommended by the 2009 IOM guidelines and 166
(8.5%) of participants failed to gain sufficient weight during
pregnancy. Accordingly, 1449 (74.3%) women in our study
had excessive GWG. These women were more likely to be
overweight or obese compared to women who gained within
or below 2009 IOM guidelines (Table 3). They were also at
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Table 2: Demographic details by centre of those included and excluded from study.
Auckland cohort Adelaide cohort Cork cohort
Included Excluded P Included Excluded P Included Excluded P
𝑁 = 264 𝑁 = 1752 𝑁 = 475 𝑁 = 679 𝑁 = 1211 𝑁 = 560
Age (years)∗ 30.4 (4.9) 30.4 (4.7) 0.88 24.3 (5.0) 23.4 (5.2) 0.005 29.9 (4.5) 30.1 (4.5) 0.39
Caucasian ethnicity∗ 216 (82) 1480 (85) 0.27 435 (92) 624 (92) 0.85 1183 (98) 547 (98) 0.99
Body mass index (kg/m2)∗ 24.5 (3.7) 24.8 (4.2) 0.36 27.5 (6.2) 26.7 (6.8) 0.04 25.0 (4.2) 24.6 (4.1) 0.07
Socioeconomic index score∗ 48 (15) 48 (15) 0.61 28 (10) 28 (10) 0.59 42 (16) 43 (16) 0.06
Smoking status∗ 0.72 0.008 0.39
Nonsmoker 230 (87) 1545 (88) 313 (66) 389 (57) 872 (72) 411 (73)
Stopped during pregnancy 25 (10) 141 (8) 68 (14) 108 (16) 210 (17) 101 (18)
Current smoker 9 (3) 66 (4) 94 (20) 182 (27) 129 (11) 48 (9)
Data are mean (SD) or number (%) as appropriate.
∗Data collected at 14–16 weeks of gestation.
P value comparison is between “included in cohort” versus “not included in cohort” GWG groups using Chi-square or independent samples 𝑡-test.
Table 3: Maternal characteristics and pregnancy outcomes by gestational weight gain categories (𝑛 = 1950).
Weight gain category (by 2009 IOM guidelines)
Not excessive
(𝑛 = 501; 25.7%)
Excessive
(𝑛 = 1449; 74.3%) 𝑃
Recruitment centre <0.001
Adelaide 157 (31.3) 318 (22.0)
Cork 243 (48.5) 968 (66.8)
Auckland 101 (20.2) 163 (11.2)
Age (years)∗ 28.7 (5.6) 28.5 (5.2) 0.67
Ethnicity 0.10
Caucasian 468 (93.4) 1366 (94.3)
Asian 12 (2.4) 15 (1.0)
Polynesian (Maori & Pacific Island) 3 (0.6) 18 (1.2)
Indian 10 (2.0) 20 (1.4)
Other (including African) 8 (1.6) 30 (2.1)
Socioeconomic index∗ 39.5 (16.0) 39.4 (16.1) 0.97
Body mass index (kg/m2)∗ 24.6 (4.8) 25.9 (4.8) <0.001
Smoking status∗ 0.001
Nonsmoker 380 (75.8) 1035 (71.4)
Stopped during pregnancy 53 (10.6) 250 (17.3)
Current smoker 68 (13.6) 164 (11.3)
Pregnancy-induced hypertension 54 (10.8) 242 (16.7) 0.001
Preeclampsia 16 (3.2) 79 (5.5)
Gestational hypertension 38 (7.6) 163 (11.2)
Mode of delivery 0.001
Caesarean section (prelabour) 35 (7.0) 154 (10.6)
Caesarean section (in labour) 77 (15.4) 295 (20.4)
Vaginal birth 389 (77.6) 1000 (69.0)
Birth weight (g) 3301 (522) 3523 (535) <0.001
Gestation at delivery (wks) 39.8 (1.8) 39.9 (1.6) 0.12
SGA infant 77 (15.4) 135 (9.3) <0.001
LGA infant 21 (4.2) 198 (13.7) <0.001
Data are mean (SD) or number (%) as appropriate.
IOM: Institute of Medicine; SGA: small for gestational age; LGA: large for gestational age.
∗Data collected at 14–16 weeks’ of gestation.
P value comparison is between “not excessive” versus “excessive” GWG groups using Chi-square or independent samples 𝑡-test.
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Table 4: Multivariable associations with excessive gestational weight gain (𝑛 = 1950).
Weight gain category (by 2009 IOM guidelines)
Not excessive (𝑛 = 501; 25.7%) Excessive (𝑛 = 1449; 74.3%)
𝑛 (%) or mean ± SD 𝑛 (%) or mean ± SD Unadjusted OR(95% CI)
Adjusted OR
(95% CI)†
Centre
Adelaide 157 (31.3) 318 (22.0) 1.26 (0.91–1.72) 1.03 (0.69–1.53)
Cork 243 (48.5) 968 (66.8) 2.47 (1.84, 3.32) 2.31 (1.63–3.29)
Auckland 101 (20.2) 163 (11.2) 1.0 1.0
Age (years)∗
≤24 126 (25.1) 321 (22.2) 1.24 (0.86, 1.78) 1.92 (1.24–2.97)
25–29 134 (26.8) 457 (31.5) 1.66 (1.17, 2.36) 1.88 (1.29–2.73)
30–34 167 (33.3) 519 (35.8) 1.51 (1.08, 2.13) 1.59 (1.11–2.27)
≥35 74 (14.8) 152 (10.5) 1.0 1.0
BMI groups (kg/m2)∗
18.5–24.9 350 (69.9) 724 (50.0) 1.0 1.0
25.0–29.9 90 (17.9) 477 (32.9) 2.56 (1.98–3.32) 2.90 (2.20–3.82)
≥30.0 61 (12.2) 248 (17.1) 1.97 (1.45–2.67) 2.50 (1.79–3.52)
Smoking status∗
Nonsmoker 380 (75.8) 1035 (71.4) 1.0 1.0
Stopped during pregnancy 53 (10.6) 250 (17.3) 1.73 (1.26–2.38) 1.67 (1.18–2.36)
Current smoker 68 (13.6) 164 (11.3) 0.89 (0.65–1.20) 0.94 (0.65–1.36)
Mother’s birth weight per 500 g increase† 3228 (585) 3353 (546) 1.22 (1.11–1.34) 1.15 (1.02–1.28)
Immigrant in past 5 years
No 460 (26.3) 1290 (20.5) 1.0 1.0
Yes 41 (73.7) 159 (79.5) 1.38 (0.95, 2.01) 1.57 (1.05–2.35)
Fertility treatment
No 465 (92.8) 1381 (95.3) 1.0 1.0
Yes 36 (7.2) 68 (4.7) 0.64 (0.41, 0.99) 0.59 (0.37–0.93)
Fish or seafood intake (servings/week)∗
<3 489 (97.6) 1365 (94.2) 1.0 1.0
≥3 12 (2.4) 84 (5.8) 2.51 (1.36–4.63) 2.75 (1.45–5.22)
Limiting behaviour score‡ 7.2 (3.7) 8.0 (4.0) 1.05 (1.03–1.08) 1.04 (1.01–1.07)
Exercise in pregnancy∗
Unchanged 200 (39.9) 452 (31.2) 1.00 1.0
Increased 27 (5.4) 71 (4.9) 1.16 (0.71, 1.92) 0.91 (0.55–1.51)
Decreased 274 (54.7) 926 (63.9) 1.50 (1.20, 1.86) 1.30 (1.01–1.69)
Sleep (hours/weeknight)∗
<8 143 (28.5) 323 (22.3) 1.0 1.0
8-9 302 (60.3) 904 (62.4) 1.33 (1.05–1.68) 1.40 (1.09–1.81)
≥10 56 (11.2) 222 (15.3) 1.76 (1.23–2.50) 1.83 (1.24–2.69)
Data are mean (SD) or number (%) as appropriate.
CI: confidence interval; BMI: body mass index; IOM: Institute of Medicine; OR: odds ratio; SD: standard deviation.
∗Data collected at 14–16 weeks of gestation.
†Multivariate regression model presented as odds ratios with 95% confidence intervals. Multivariable model controls for all variables in the table.
‡The limiting behaviour score ranges from 0 to 20 with higher values corresponding with greater limiting behaviour; OR refers to a one unit change in score.
greater risk of Caesarean section in labour, LGA infants, and
hypertensive disorders of pregnancy.
After identification of statistically significant variables
associated with excessive GWG in univariable analyses, a
multivariable logistic regressionmodel was developed to esti-
mate factors independently associated with excessive GWG.
The unadjusted and adjusted OR and corresponding 95%
confidence intervals are shown in Table 4.
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In the final multivariable model, overweight women at
14–16 weeks’ gestation were nearly three times as likely to
exceed GWG ranges (95% CI 2.20, 3.82) compared to those
with a normal BMI, while obese women were approximately
2.5 times more at risk of excessive GWG (95% CI 1.79, 3.52).
Compared to the referent group of women aged 35 years or
more, younger women had a higher risk of excessive GWG,
with women aged less than 25 years at an almost 2-fold
increase in risk. Additional models controlling for maternal
educational status and family income level (as a marker of
socioeconomic status) were run. These had no effect on
the relationship between maternal age and excessive GWG
in the model. Women who ceased smoking in pregnancy
also had elevated risk (adjusted OR 1.67, 95% CI 1.17, 2.35).
Additionally, the risk of excessive GWG increased by 15% (CI
1.02–1.28) for every 500 g increase in maternal birth weight.
No relationship between maternal birth weight and infant
birth weight was found (R2 = 0.037).
Hours of sleep on weekday nights were also positively
correlated with excessive GWG with those women who slept
for 10 or more hours a night being at higher risk of excessive
GWG by nearly twofold compared to women who reported
sleeping less than 8 hours. Women who reported a decrease
in exercise by 14–16 weeks were 50% more likely to have
excessive GWG and women who recorded greater limiting
behaviours were more likely to gain above the 2009 IOM
guidelines (adjusted OR = 1.04, CI 1.01–1.07). Other factors
associated with excessive GWG included a high intake of fish
or seafood (adjustedOR= 2.75, CI 1.45, 5.22), being amigrant
in the previous five years (adjusted OR = 1.57, CI 1.05, 32.35),
living in Cork (adjusted OR = 2.31, CI 1.63, 3.29) compared
to Auckland. The use of fertility treatment to conceive the
current pregnancy was the only protective factor identified
(adjusted OR 0.59, CI 0.37–0.93). The relationship between
fertility treatment and infant birth weight was not significant
(𝑃 = 0.98).
4. Discussion
In this cohort of healthy, nulliparous pregnant women
recruited between 2004 and 2011, nearly three quarters
(74.3%), gained weight in excess of the 2009 IOM guidelines.
Total weight gain was approximately two kilograms less in
obese participants but because of the lower recommended
optimal GWG in obese women they were 2.5 times as likely
(CI 1.77–3.51) to exceed IOMweight gain guidelines. Similarly
overweight women were also at increased risk of excessive
GWG. Our findings are consistent with previous reports
which indicate that high pregravid/early pregnancy BMI is a
strong predictor of excessive GWG, despite absolute weight
gains being lower compared to women with a normal BMI
[19–22, 27–32]. These findings are concerning as excessive
GWG is an important pathway to postpartum weight reten-
tion and the development of new or persistent obesity in
women of reproductive age and also their offspring [15, 44].
This has major implications for long-term individual health
and future health care costs to a society already burdened by
obesity.
Our study has shown that excessive GWG is influenced
by nonmodifiable risk factors including maternal age and
birth weight. Women aged less than 25 years and 25–29
years are almost twice as likely and women 30–34 years
60% are more likely to gain above IOM guidelines compared
to women aged 35 years or more. Our findings regarding
age are consistent with the majority of previous reports
which have found that young mothers are at greater risk of
exceedingGWGguidelines [26, 28, 30] whereas older women
tend to gain less weight during pregnancy [18, 28, 30]. It is
unusual for advanced maternal age to be a protective factor
against an adverse outcome. Possible explanations include a
poor anabolic response to pregnancy or alternatively older
women may be more disciplined regarding lifestyle choices.
We also report a novel independent association between
the mother’s birth weight and her risk of excessive GWG
(aOR 1.17, CI 1.06–1.29 per 500 g) which was not explained
by a correlation between maternal and infant birth weight.
A possible explanation is that higher birth weight women
are themselves programmed for positive energy balance. In
contrast, the use of fertility treatment to conceive the current
pregnancy was associated with an approximate 40% lower
risk of excessive GWG, which was not explained by lower
infant birth weight.
Women who quit smoking before 14–16 weeks of ges-
tation were 50% more likely to exceed 2009 IOM GWG
guidelines compared to nonsmokers.This was not accounted
for by a difference in birth weight between nonsmokers and
ceased smokers which were virtually identical. Weight gain
after stopping smoking is likely multifactorial. Withdrawal of
the appetite suppressant effects of nicotine and replacement
of smoking with consumption of foods high in sugar and
fat which activate neural reward pathways similar to those
activated by smoking may all contribute to the overcon-
sumption of energy on quitting smoking [45]. Only limited
previous evidence is available regarding smoking cessation
during pregnancy and risk of excessive GWG [23, 25, 28].
Favaretto et al. found that quitting smoking after conception
increased the odds of excessive GWG by 34% (95% CI 1.10–
1.63) compared to nonsmokers [23]. Interestingly, Favaretto
et al. alsonoted that women who quit smoking within six
months of conception gained on average 1.0 kg more than
nonsmokers, compared to an extra 1.5 kg gained by women
who quit smoking after conception [23]. It may therefore be
advisable to counsel women on the benefits of quitting prior
to conception in an attempt to limit excessive GWG, as well
as providing comprehensive nutritional and exercise advice
to those who quit in pregnancy.
We also examined a number of lifestyle factors whichmay
impact on GWG. While excess television viewing (>5 hours
per day) and computer usage were associated with excessive
GWG in our univariable analyses, these factors were no
longer significant in the multivariable model. Sleep duration
on weekday nights remained an independent risk factor for
excessive GWG in our multivariable analysis. Women who
slept for ten hours or more were nearly twice as likely to
exceed 2009 IOM recommendations compared to women
who reported less than eight hours of sleep nightly. While
these results are contrary to findings from Althuizen et al.,
Journal of Obesity 7
which links a reduction in nocturnal sleep with increased
GWG [19], a larger study has recently identified sleep depri-
vation as a risk factor for inadequate GWG [46]. When we
compared sleep duration in the “low” versus “normal” GWG
groups we found no significant difference. The mechanism
underlying our findings is not understood but may include
less time available for physical activity. Further research is
needed to fully elucidate the influence of sleep on weight gain
in pregnancy.Our findings also show, asmight be anticipated,
that womenwho exhibit greater “limiting behavior” [41] (e.g.,
by restricting their usual level of activity, avoiding physical
exercise, going to bed during the daytime, and putting their
life on hold) are at greater risk of excessive GWG.
Dietary intake was also assessed during the 14–16 weeks
of gestation SCOPE visit. Although reported intake of fruits
and vegetables did not influence GWG, consuming three or
more servings of fish or seafood perweekwas an independent
risk factor for excessive GWG (adjOR = 2.96, CI 1.53, 5.74).
Further exploration of our data confirmed that this relation-
ship between high fish intake and excessive gestational weight
gain was not a surrogate for eating deep fried hot potato chips
(“fish and chips”) as the association between high fish intake
and excessive GWG remained after adjustment for chips. It
is possible that high fish or seafood intake may reflect a
participant’s total energy intake, a factor which has previously
been associated with excessive GWG but was not measured
in our cohort [19, 24, 27, 30]. An effect of fish on satiety may
also be possible as a recent small randomised controlled trial
of fish oil supplements reported that supplementation was
associatedwith increased appetite in female participants [47].
It is unclear why the cohort of women in Cork had a
higher risk of excessive GWG. It is possible that local societal-
cultural factors regarding expected weight gain in pregnancy
(i.e., eating for two) may have played a part.
Strengths of our study include the novel study population
comprising a cohort of healthy, nulliparous women, and the
large subgroup with excessive GWG [20–22, 24, 30, 32]. In
addition, all anthropometric measurements were obtained
by a research midwife to ensure that BMI at 14–16 weeks of
gestation was calculated accurately, thereby eliminating the
potential for self-reporting bias. Our findings are also based
on the recently updated 2009 IOM pregnancy weight gain
guidelines [2] and are adjusted for gestational length rather
than total weight gain.
Several factors which may limit the reliability of our
study however should be noted. Prepregnancy weight mea-
surements were not available and have been estimated using
methodology recommended by the 2009 IOM guidelines
[2]. However, this will have minimal impact on the value
of prepregnancy BMI as weight gain in the first trimester of
pregnancy is small. Additionally, it is possible that modifiable
behaviours assessed at 14–16 weeks of gestation did not reflect
behaviours over the course of the pregnancy.
5. Conclusion
Nearly three quarters of the participants in our cohort had
excessive GWG. We have identified some modifiable and
nonmodifiable risk factors for excessive GWG. Women at
increased risk could be targeted for future intervention
studies.
Conflict of Interests
Antonia Restall, Rennae S. Taylor, John M. D. Thompson,
Deralie Flower, Gustaaf A. Dekker, Lucilla Poston, Lesley
M. E. McCowan declare that there is no conflict of interests
regarding the publication of this article. Louise C. Kenny is a
minority shareholder in Metabolomic Diagnostics, a campus
based spinout which has licenced technology concerning
the use of metabolomics biomarkers in the prediction of
preeclampsia. Louise C. Kenny has received consultancy fees
and honoraria, payments from Alere relating to the Triage
PlGF test for the prediction of complications in women with
suspected preeclampsia.
Acknowledgments
The authors would like to thank the pregnant women who
participated in the SCOPE study, Eliza Chan for statistical
assistance, Associate Professor Claire Roberts for her contri-
butions in establishing the SCOPE study in Adelaide, Denise
Healy for coordinating the Australian SCOPE study, Nicolai
Murphy for coordinating the Cork SCOPE study, and the
SCOPE research midwives. Louise C. Kenny is the Director
of the Irish Centre for Fetal and Neonatal Translational
Research (INFANT) funded by Science Foundation Ireland
(Grant SFI 12/RC/2272).The authorswish to acknowledge the
funders of the SCOPE study. They would like to thank New
Zealand: New Enterprise Research Fund, Foundation for
Research Science and Technology; Health Research Council
04/198; Evelyn Bond Fund, Auckland District Health Board
Charitable Trust; Australia: Premier’s Science and Research
Fund, South Australian Government; Cork, Ireland Health
Research Board.
References
[1] Institute of Medicine, Nutrition during Pregnancy, National
Academy Press, Washington, DC, USA, 1990.
[2] K. M. Rasmussen and A. L. Yaktine, Weight Gain during
Pregnancy: Reexamining the Guidelines, National Academies
Press, Washington, DC, USA, 2009.
[3] A. R. Amorim, S. Ro¨ssner, M. Neovius, P. M. Lourenc¸o, and Y.
Linne´, “Does excess pregnancy weight gain constitute a major
risk for increasing long-term BMI?” Obesity, vol. 15, no. 5, pp.
1278–1286, 2007.
[4] G. Kac, M. H. D. A. Benı´cio, G. Vela´squez-Mele´ndez, J. G.
Valente, and C. J. Struchiner, “Gestational weight gain and
prepregnancy weight influence postpartum weight retention in
a cohort of Brazilian women,” Journal of Nutrition, vol. 134, no.
3, pp. 661–666, 2004.
[5] Z. Chen, J. Du, L. Shao et al., “Prepregnancy body mass index,
gestational weight gain, and pregnancy outcomes in China,”
International Journal of Gynecology & Obstetrics, vol. 109, no.
1, pp. 41–44, 2010.
[6] D.W. Kiel, E. A. Dodson, R. Artal, T. K. Boehmer, and T. L. Leet,
“Gestational weight gain and pregnancy outcomes in obese
8 Journal of Obesity
women: how much is enough?” Obstetrics and Gynecology, vol.
110, no. 4, pp. 752–758, 2007.
[7] A. Beyerlein, B. Schiessl, N. Lack, and R. von Kries, “Optimal
gestational weight gain ranges for the avoidance of adverse birth
weight outcomes: a novel approach,” The American Journal of
Clinical Nutrition, vol. 90, no. 6, pp. 1552–1558, 2009.
[8] L. M. Bodnar, A. M. Siega-Riz, H. N. Simhan, K. P. Himes, and
B. Abrams, “Severe obesity, gestational weight gain, and adverse
birth outcomes,”TheAmerican Journal of Clinical Nutrition, vol.
91, no. 6, pp. 1642–1648, 2010.
[9] C. E. M. Zilko, D. Rehkopf, and B. Abrams, “Association of
maternal gestational weight gain with short- and long-term
maternal and child health outcomes,” American Journal of
Obstetrics and Gynecology, vol. 202, no. 6, pp. 574.e1–574.e8,
2010.
[10] E. A. Nohr, M. Vaeth, J. L. Baker, T. I. Sørensen, J. Olsen, and K.
M. Rasmussen, “Combined associations of prepregnancy body
mass index and gestational weight gain with the outcome of
pregnancy,” The American Journal of Clinical Nutrition, vol. 87,
no. 6, pp. 1750–1759, 2008.
[11] A. A. Mamun, L. K. Callaway, M. J. O’Callaghan et al., “Associ-
ations of maternal pre-pregnancy obesity and excess pregnancy
weight gains with adverse pregnancy outcomes and length of
hospital stay,” BMC Pregnancy and Childbirth, vol. 11, article 62,
2011.
[12] A. A. Mamun, M. O’Callaghan, L. Callaway, G. Williams, J.
Najman, and D. A. Lawlor, “Associations of gestational weight
gain with offspring body mass index and blood pressure at 21
years of ageevidence from a birth cohort study,”Circulation, vol.
119, no. 13, pp. 1720–1727, 2009.
[13] R. Ensenauer, A. Chmitorz, C. Riedel et al., “Effects of subop-
timal or excessive gestational weight gain on childhood over-
weight and abdominal adiposity: results from a retrospective
cohort study,” International Journal of Obesity, vol. 37, no. 4, pp.
505–512, 2013.
[14] E. Oken, E.M. Taveras, K. P. Kleinman, J.W. Rich-Edwards, and
M. W. Gillman, “Gestational weight gain and child adiposity at
age 3 years,”American Journal of Obstetrics and Gynecology, vol.
196, no. 4, pp. 322.e1–322.e8, 2007.
[15] B. H. Wrotniak, J. Shults, S. Butts, and N. Stettler, “Gestational
weight gain and risk of overweight in the offspring at age 7 y in
a multicenter, multiethnic cohort study,”The American Journal
of Clinical Nutrition, vol. 87, no. 6, pp. 1818–1824, 2008.
[16] A. Fraser, K. Tilling, C. MacDonald-Wallis et al., “Association
ofmaternal weight gain in pregnancy with offspring obesity and
metabolic and vascular traits in childhood,”Circulation, vol. 121,
no. 23, pp. 2557–2564, 2010.
[17] L. Poston, “Developmental programming and diabetes—the
human experience and insight from animal models,” Best
Practice & Research: Clinical Endocrinology & Metabolism, vol.
24, no. 4, pp. 541–552, 2010.
[18] B. Abrams, S. Carmichael, and S. Selvin, “Factors associated
with the pattern of maternal weight gain during pregnancy,”
Obstetrics and Gynecology, vol. 86, no. 2, pp. 170–176, 1995.
[19] E. Althuizen, M. N. M. van Poppel, J. C. Seidell, and W. van
Mechelen, “Correlates of absolute and excessive weight gain
during pregnancy,” Journal of Women’s Health, vol. 18, no. 10,
pp. 1559–1566, 2009.
[20] P. Brawarsky, N. E. Stotland, R. A. Jackson et al., “Pre-pregnancy
and pregnancy-related factors and the risk of excessive or
inadequate gestational weight gain,” International Journal of
Gynecology & Obstetrics, vol. 91, no. 2, pp. 125–131, 2005.
[21] L. E. Caulfield, F. R. Witter, and R. J. Stoltzfus, “Determinants
of gestational weight gain outside the recommended ranges
among black and white women,”Obstetrics and Gynecology, vol.
87, no. 5, part 1, pp. 760–766, 1996.
[22] L. Chasan-Taber, M. D. Schmidt, P. Pekow, B. Sternfeld, C.
G. Solomon, and G. Markenson, “Predictors of excessive and
inadequate gestational weight gain in hispanic women,”Obesity,
vol. 16, no. 7, pp. 1657–1666, 2008.
[23] A. L. Favaretto, B. B. Duncan, S. S. Mengue et al., “Prenatal
weight gain following smoking cessation,” European Journal of
Obstetrics Gynecology and Reproductive Biology, vol. 135, no. 2,
pp. 149–153, 2007.
[24] S. J. Herring, D. B. Nelson, A. Davey et al., “Determinants of
excessive gestationalweight gain in urban, low-incomewomen,”
Women’s Health Issues, vol. 22, no. 5, pp. e439–e446, 2012.
[25] M. Mongoven, P. Dolan-Mullen, J. Y. Groff, L. Nicol, and K.
Burau, “Weight gain associatedwith prenatal smoking cessation
in white, non-hispanic women,” American Journal of Obstetrics
and Gynecology, vol. 174, no. 1, part 1, pp. 72–77, 1996.
[26] A. S. Olafsdottir, G. V. Skuladottir, I. Thorsdottir, A. Hauks-
son, and L. Steingrimsdottir, “Maternal diet in early and late
pregnancy in relation to weight gain,” International Journal of
Obesity, vol. 30, no. 3, pp. 492–499, 2006.
[27] C. M. Olson and M. S. Strawderman, “Modifiable behavioral
factors in a biopsychosocial model predict inadequate and
excessive gestational weight gain,” Journal of the American
Dietetic Association, vol. 103, no. 1, pp. 48–54, 2003.
[28] P. L. Rodrigues, L. C. de Oliveira, A. D. S. Brito, and G. Kac,
“Determinant factors of insufficient and excessive gestational
weight gain and maternal-child adverse outcomes,” Nutrition,
vol. 26, no. 6, pp. 617–623, 2010.
[29] I. M. Strychar, C. Chabot, F. Champagne et al., “Psychosocial
and lifestyle factors associated with insufficient and excessive
maternal weight gain during pregnancy,” Journal of the Ameri-
can Dietetic Association, vol. 100, no. 3, pp. 353–356, 2000.
[30] A.M. Stuebe, E. Oken, andM.W. Gillman, “Associations of diet
and physical activity during pregnancy with risk for excessive
gestational weight gain,” American Journal of Obstetrics and
Gynecology, vol. 201, no. 1, pp. 58.e1–58.e8, 2009.
[31] C. S. Weisman, M. M. Hillemeier, D. S. Downs, C. H. Chuang,
and A.-M. Dyer, “Preconception predictors of weight gain
during pregnancy: prospective findings from the Central Penn-
sylvania Women’s Health Study,”Women’s Health Issues, vol. 20,
no. 2, pp. 126–132, 2010.
[32] C. S. Wells, R. Schwalberg, G. Noonan, and V. Gabor, “Factors
influencing inadequate and excessive weight gain in pregnancy:
Colorado, 2000–2002,”Maternal and Child Health Journal, vol.
10, no. 1, pp. 55–62, 2006.
[33] National Perinatal Reporting System, Perinatal Statistics Report
2010, National Perinatal Reporting System, Ireland, 2012.
[34] Infoshore, Total Confinements by District Health Board by Pre-
vious Births, StatisticsNew Zealand, Wellington, New Zealand,
2011.
[35] Z. Li, R. Zeki, L. Hilder, and E. A. Sullivan, Australian Mothers
and Babies 2010, Perinatal Statistics Series no. 27. Cat. no. PER
57, AIHWNational Perinatal Epidemiology and Statistics Unit,
Canberra, Australia, 2012.
[36] J. G. Y. Chung, R. S. Taylor, J. M. D. Thompson et al.,
“Gestational weight gain and adverse pregnancy outcomes in a
nulliparous cohort,” European Journal of Obstetrics Gynecology
and Reproductive Biology, vol. 167, no. 2, pp. 149–153, 2013.
Journal of Obesity 9
[37] L. M. E. McCowan, C. T. Roberts, G. A. Dekker et al., “Risk
factors for small-for-gestational-age infants by customised
birthweight centiles: data from an international prospective
cohort study,” BJOG, vol. 117, no. 13, pp. 1599–1607, 2010.
[38] R. A. North, L. M. E. McCowan, G. A. Dekker et al., “Clinical
risk prediction for pre-eclampsia in nulliparous women: devel-
opment of model in international prospective cohort,” British
Medical Journal, vol. 342, no. 7803, Article ID d1875, 2011.
[39] D. E. Durie, L. L.Thornburg, and J. C. Glantz, “Effect of second-
trimester and third-trimester rate of gestational weight gain on
maternal and neonatal outcomes,” Obstetrics and Gynecology,
vol. 118, no. 3, pp. 569–575, 2011.
[40] C. Galbraith, G. Jenkin, P. Davis, and P. Coope, New
Zealand Socio-Economic Index 1996—Users Guide, Statistics
New Zealand, Wellington, New Zealand, 2003.
[41] M. Spence, R. Moss-Morris, and T. Chalder, “The Behavioural
Responses to Illness Questionnaire (BRIQ): a new predictive
measure of medically unexplained symptoms following acute
infection,” Psychological Medicine, vol. 35, no. 4, pp. 583–593,
2005.
[42] M. A. Brown, M. D. Lindheimer, M. de Swiet, A. van Assche,
and J.-M. Moutquin, “The classification and diagnosis of the
hypertensive disorders of pregnancy: statement from the Inter-
national Society for the Study of Hypertension in Pregnancy
(ISSHP),” Hypertension in Pregnancy, vol. 20, no. 1, pp. 9–14,
2001.
[43] L. M. E. McCowan, J. E. Harding, and A. W. Stewarf, “Cus-
tomised birthweight centiles predict SGA pregnancies with
perinatal morbidity,” BJOG, vol. 112, no. 8, pp. 1026–1033, 2005.
[44] S. A. Gore, D. M. Brown, and D. S. West, “The role of
postpartumweight retention in obesity amongwomen: a review
of the evidence,” Annals of Behavioral Medicine, vol. 26, no. 2,
pp. 149–159, 2003.
[45] J. Audrain-Mcgovern and N. L. Benowitz, “Cigarette smoking,
nicotine, and body weight,” Clinical Pharmacology and Thera-
peutics, vol. 90, no. 1, pp. 164–168, 2011.
[46] C. Abeysena and P. Jayawardana, “Sleep deprivation, physical
activity and low income are risk factors for inadequate weight
gain during pregnancy: a cohort study,” Journal of Obstetrics and
Gynaecology Research, vol. 37, no. 7, pp. 734–740, 2011.
[47] S. Damsbo-Svendsen, M. D. Rønsholdt, and L. Lauritzen, “Fish
oil-supplementation increases appetite in healthy adults. A
randomized controlled cross-over trial,” Appetite, vol. 66, pp.
62–66, 2013.
Submit your manuscripts at
http://www.hindawi.com
Stem Cells
International
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
MEDIATORS
INFLAMMATION
of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Behavioural 
Neurology
Endocrinology
International Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Disease Markers
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
BioMed 
Research International
Oncology
Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Oxidative Medicine and 
Cellular Longevity
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
PPAR Research
The Scientific 
World Journal
Hindawi Publishing Corporation 
http://www.hindawi.com Volume 2014
Immunology Research
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Journal of
Obesity
Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
 Computational and  
Mathematical Methods 
in Medicine
Ophthalmology
Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Diabetes Research
Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Research and Treatment
AIDS
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Gastroenterology 
Research and Practice
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Parkinson’s 
Disease
Evidence-Based 
Complementary and 
Alternative Medicine
Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com
